Baidu
map

轰动欧美!海外科学家公布铁证:中药轻松杀死癌细胞

2017-09-02 佚名 全球肿瘤医生网

国际肿瘤研究领域的著名学术期刊《癌症快报》(Cancer Letters)刊登了复方苦参注射液能够有效治疗癌症疼痛,减轻癌症患者痛苦的研究成果。研究表明,该药同时还能抑制肿瘤增值,是中药注射液用于肿瘤治疗研究的重大突破。事实证明,中国医学的崛起已势不可挡!



国际肿瘤研究领域的著名学术期刊《癌症快报》(Cancer Letters)刊登了复方苦参注射液能够有效治疗癌症疼痛,减轻癌症患者痛苦的研究成果。研究表明,该药同时还能抑制肿瘤增值,是中药注射液用于肿瘤治疗研究的重大突破。事实证明,中国医学的崛起已势不可挡!

1、中国传统医学的一次伟大胜利:复方苦参注射液,获准治疗各种癌症肿瘤

墙内开花墙外香!

日前,澳州阿德莱德大学科研团队,

在世界权威学术周刊《肿瘤学目标》上发表重大研究成果!



科学家宣布,终于研究清楚中国传统医学使用中草药治疗癌症的复杂机制!

中国中医中草药复方苦参(Compound kushen injection,CKI)在杀死癌细胞方面有奇迹般的效果。

研究人言发现,复方苦参注射液能够改变控制细胞内部分裂和死亡的基因,并且改变细胞循环使癌细胞变成死亡细胞,也就是杀死癌细胞。

阿德莱德大学的这一项最新研究,证实传统中医能够杀死癌细胞。


在中国,复方苦参注射液(Compound kushen injection, CKI)获准治疗各种癌症肿瘤,通常是作为辅助西方医学的化疗。

但是,尽管已验证了这种药物的功效,但其抗癌原理一直是个谜!

这次研究是全球对复方苦参进行的首次研究,而且重点是其分子杀死癌细胞的运作原理,而不是分析它的成分。

研究负责人David Adelson指出:“大部分传统中草药的使用是基于中国人千百年来的传统经验。有大量证据都证明中草药在一些疾病的治疗过程中确实有疗效,但没有人知道原理。”
“经过我们的研究,我们可以确认中草药在杀灭癌细胞上有显着功效,这是非常神奇的,非常令人惊讶”!



2、复方苦参注射液治癌机理在于:能够调节癌细胞的分裂和生存周期

这一研究由研究人员发表在国际医学杂志《肿瘤标靶》(Oncotarget)上,证实了传统中医中的复方苦参注射液能够引起基因表现类型的变化,而且复方苦参注射液还可以作用于类型不同的癌细胞中的各种基因。

Adelson教授解释说,这些基因能够调节细胞的分裂和生存周期,中药方似乎改变了正在调节中的细胞周期,促使癌细胞朝着死亡的途径上发展,进而最终杀死癌细胞。

据了解,复方苦参注射液是传统中医中有名的治疗方法,所含药物由苦参和白土苓根部提取,而且包含多种化学成分,包括生物碱,例如苦参碱(matrine)、氧化苦参碱(oxymatrine)、黄酮类(flavonoids)等。

中医配方将会为西方医学界攻克癌症提供新的解决思路!

像其他传统中医一样,复方苦参注射液的单独成分并不会产生杀死癌细胞的效果,而混合在一起之后,它就能治疗多种癌症,而且潜在的人体副作用也大大减小!



这项最新的权威科研成果在全球医学界的引发巨大反响!

诺贝尔医学奖得主Harald zur Hausen,他在看到这个伟大的研究成果后,也发表声明称中医在治愈癌症上会有显着的效果!

中国医学博大精深,是巨大财富,需要不断探索,标准化,科学化!



一股中草药热潮席卷欧洲,美国、加拿大、澳州……

中国医学崛起已势不可挡 !

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1748917, encodeId=03bf1e4891783, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Wed Nov 29 02:36:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252338, encodeId=9ec21252338a8, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Mon Sep 04 03:36:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239873, encodeId=b5be2398e35e, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Sep 03 01:00:19 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239757, encodeId=d966239e570f, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sat Sep 02 15:13:30 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239732, encodeId=49e2239e32b0, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Sat Sep 02 13:14:26 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239726, encodeId=97a5239e2662, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Sep 02 13:00:13 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239723, encodeId=c4f5239e232e, content=不错的文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sat Sep 02 12:53:38 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-11-29 lishizhe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1748917, encodeId=03bf1e4891783, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Wed Nov 29 02:36:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252338, encodeId=9ec21252338a8, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Mon Sep 04 03:36:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239873, encodeId=b5be2398e35e, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Sep 03 01:00:19 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239757, encodeId=d966239e570f, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sat Sep 02 15:13:30 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239732, encodeId=49e2239e32b0, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Sat Sep 02 13:14:26 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239726, encodeId=97a5239e2662, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Sep 02 13:00:13 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239723, encodeId=c4f5239e232e, content=不错的文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sat Sep 02 12:53:38 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-04 yxch36
  3. [GetPortalCommentsPageByObjectIdResponse(id=1748917, encodeId=03bf1e4891783, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Wed Nov 29 02:36:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252338, encodeId=9ec21252338a8, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Mon Sep 04 03:36:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239873, encodeId=b5be2398e35e, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Sep 03 01:00:19 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239757, encodeId=d966239e570f, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sat Sep 02 15:13:30 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239732, encodeId=49e2239e32b0, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Sat Sep 02 13:14:26 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239726, encodeId=97a5239e2662, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Sep 02 13:00:13 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239723, encodeId=c4f5239e232e, content=不错的文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sat Sep 02 12:53:38 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-03 明天会更好!

    学习了.谢谢分享.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1748917, encodeId=03bf1e4891783, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Wed Nov 29 02:36:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252338, encodeId=9ec21252338a8, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Mon Sep 04 03:36:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239873, encodeId=b5be2398e35e, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Sep 03 01:00:19 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239757, encodeId=d966239e570f, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sat Sep 02 15:13:30 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239732, encodeId=49e2239e32b0, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Sat Sep 02 13:14:26 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239726, encodeId=97a5239e2662, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Sep 02 13:00:13 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239723, encodeId=c4f5239e232e, content=不错的文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sat Sep 02 12:53:38 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-02 189****7206

    学习了受益匪浅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1748917, encodeId=03bf1e4891783, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Wed Nov 29 02:36:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252338, encodeId=9ec21252338a8, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Mon Sep 04 03:36:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239873, encodeId=b5be2398e35e, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Sep 03 01:00:19 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239757, encodeId=d966239e570f, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sat Sep 02 15:13:30 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239732, encodeId=49e2239e32b0, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Sat Sep 02 13:14:26 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239726, encodeId=97a5239e2662, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Sep 02 13:00:13 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239723, encodeId=c4f5239e232e, content=不错的文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sat Sep 02 12:53:38 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-02 飘飘爱

    很好

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1748917, encodeId=03bf1e4891783, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Wed Nov 29 02:36:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252338, encodeId=9ec21252338a8, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Mon Sep 04 03:36:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239873, encodeId=b5be2398e35e, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Sep 03 01:00:19 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239757, encodeId=d966239e570f, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sat Sep 02 15:13:30 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239732, encodeId=49e2239e32b0, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Sat Sep 02 13:14:26 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239726, encodeId=97a5239e2662, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Sep 02 13:00:13 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239723, encodeId=c4f5239e232e, content=不错的文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sat Sep 02 12:53:38 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-02 flysky120

    学习一下知识

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1748917, encodeId=03bf1e4891783, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Wed Nov 29 02:36:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252338, encodeId=9ec21252338a8, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Mon Sep 04 03:36:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239873, encodeId=b5be2398e35e, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Sep 03 01:00:19 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239757, encodeId=d966239e570f, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sat Sep 02 15:13:30 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239732, encodeId=49e2239e32b0, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Sat Sep 02 13:14:26 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239726, encodeId=97a5239e2662, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Sep 02 13:00:13 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239723, encodeId=c4f5239e232e, content=不错的文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sat Sep 02 12:53:38 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-02 131****2916

    不错的文章值得学习

    0

相关资讯

盘点:近期中医药的研究进展一览

结果:研究共纳入了23名女性和21名男性红细胞生成性原卟啉症患者,他们的平均年龄为37.6岁。T-评分的平均SD为:腰椎,-1.12;股骨颈,-0.82(P<0.001)。23.1%的患者出现了骨量减少,35.9%的患者出现了骨质疏松症的现状。基于参考亚组的预期患病率分别为15%和0.6%。维生素D缺乏症的患病率为50%(定义为25羟-维生素D水平小于50 nmol/L)。自评BPAQ评分平均为1

河南:公立医院全部取消药品加成 中药饮品除外

8月26日下午,河南省卫生计生委、发展改革委、人力资源和社会保障厅、财政厅以及郑州市卫生计生委等有关部门联合召开省会公立医院综合改革动员会,自2017年8月31日零时起,省会所有公立医院全部取消药品加成(中药饮片除外),同步实施医疗服务价格调整和医保报销等配套改革。河南省人力资源和社会保障厅副厅长、省社会保障局局长郑子健,省卫生计生委副主任、党组副书记阚全程等领导出席会议并讲话,省卫生计生委副主任

七夕更火的中药情诗

写给七夕节的情诗,你有吗?

北京大学药学院屠鹏飞团队揭示中药作用新靶点

在国家自然科学基金项目等资助下,北京大学药学院天然药物与仿生药物国家重点实验室教授屠鹏飞团队研究揭示了传统中药苏木的抗神经炎症活性成分苏木酮A的直接作用靶点蛋白为肌苷-5-单磷酸脱氢酶2(IMPDH2),相关研究成果在《美国科学院院刊》上在线发表。

J Microencap:槲皮素可用于食物

槲皮素是一种称为黄酮的植物色素,是我们饮食中最丰富的抗氧化剂之一。实验室研究表明,除了成为有效的抗氧化剂之外,它还可以具有一系列有益效果,包括抗癌,抗肥胖,抗炎和抗菌等特性。

“手绘中药CP图”走红网络

“景天和雪见草,一个戒火外用止血止痛,一个消炎内服镇咳止泻,一个跳脱一个温和,真是一对欢喜冤家。”近日,一篇名为《风物|手绘中药CP图,原来可以这么美》的微信推文走红互联网,被上千余位网友传播。

Baidu
map
Baidu
map
Baidu
map